13F

Stock

Phio Pharmaceuticals Corp.

PHIO · held by 17 managers

Reported value

$371.3K

Holders

17

+0 new · −1 exited

Holders’ est. mark

−$10.6K

Price effect on 2 books still in the name

Largest holder

$97.3K

GEODE CAPITAL MANAGEMENT, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GEODE CAPITAL MANAGEMENT, LLC92.6K$97.3KHeld
Vanguard87.6K$92KHeld
Cetera Investment Advisers42.5K$44.6KHeld
NORTHERN TRUST CORP23.8K$24.9KHeld
DRW Securities, LLC22.6K$23.8KHeld
SUSQUEHANNA INTERNATIONAL GROUP, LLP20.1K$21.1KHeld
TWO SIGMA INVESTMENTS, LP14.5K$15.2KHeld
StoneX Group Inc.11.8K$12.4KHeld
Robertson Stephens Wealth Management, LLC10.8K$11.3KHeld
CAPTRUST FINANCIAL ADVISORS10K$10.5KHeld
UBS Group AG8.59K$9.02KHeld
MORGAN STANLEY6K$6.3K−$8.58KCut−$8.58K
BANK OF AMERICA CORP /DE/1.41K$1.48K−$2KCut−$1.99K
SBI Securities Co., Ltd.1.14K$1.19KHeld
ASSETMARK, INC110$116Held
Virtu Financial LLC10.2K$11Held
Activest Wealth Management9$9Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.